FROM CLINICAL DATA TO INSIGHT
Clinical Cohorts at the Intersection of the Microbiome, Immune System & Cancer Axis
Seerave Global OncoBiome Atlas is a growing catalogue of key clinical datasets at the intersection of immuno-oncology and microbiome science.
The Atlas aims to catalyze investigations and hypothesis-driven evidence-generation around the role of microbiome-modifiers in cancer therapy.
The challenge
Promising evidence is emerging at the intersection of immuno-oncology and the microbiome, yet the lack of transparent mapping of existing datasets and standardisation creates a substantial barrier for researchers and organisations seeking clinical translation.
The solution
The Seerave Global Oncobiome Atlas catalogs and provides visibility to existing, developing, and planned clinical datasets through a central reference point.
It offers concrete solutions for harmonizing data across different sites and make pathways transparent through which these resources can be accessed. This enables collaboration with the ultimate goal of improving patient outcomes by minimising redundancy and accelerating discovery.
Clinical Data
Outcome Data
Microbiome Modifier
Associated microbiome profiling and/or associated blood/stool samples yet to be analysed (multi-omics)
Granular information on exposure to medication
Lifestyle (Diet and Exercise)
Longitudinal biospecimen and patient data tracking
Standardised clinical, biospecimen and assay data capturing
Granular information on medication exposure history
Standardised bioinformatic workflows and state-of-the art microbiome profiling
Integrated multi-omic and immunotherapy response data
Impact
COHORTS
Patients
Latest
ASCO Annual Meeting 2026
29 May-2 June 2026
Chicago, USA
The upcoming ASCO Annual Meeting will bring together clinicians, researchers, and industry leaders from around the world to share cutting-edge discoveries, foster collaboration, and drive the next wave of innovation in cancer care.
ESMO Congress 2026
23-27 October 2026
Madrid, Spain
The ESMO Congress is a highly influential global oncology platform for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world.
Annual Steering Committee Meeting 2026
16-18 November 2026
Zürich, Switzerland
The Consortium is gathering to exchange the latest findings, align on vision & strategy, and strengthen the partnerships driving one of the most ambitious efforts in cancer microbiome research. A further purpose of the meeting will be to build a strategy for the next phase.
